...
首页> 外文期刊>Nuclear Medicine Communications >Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma
【24h】

Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma

机译:初步分期18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对晚期非霍奇金淋巴瘤患者定量参数的预后价值

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: This study was carried out to evaluate the role of quantitative parameters in staging PET in predicting prognosis in patients with high-grade non-Hodgkin's lymphoma (NHL). METHODS: A total of 51 histopathologically proven high-grade NHL patients treated with conventional chemotherapy regimens were included in the study. Total lesion glycolysis (TLG) and functional volumes (FVs) were defined as per the PET Response Criteria in Solid Tumors (PERCIST) criteria. All patients were followed up for a minimum period of 1 year or until an event, whichever occurred earlier. RESULTS: Of the four semiquantitative parameters studied, SUV max and SUV mean did not show a statistically significant correlation with progression-free survival or overall survival, whereas TLG and FV showed a weak but statistically significant negative correlation. Using the receiver operating characteristic curve analysis, optimal cut-offs were derived for FV and TLG to predict progression and death. Using the cut-off values of 416 cm 3 and 3340 g for FV and TLG, respectively, a statistically significant difference in progression-free survival and overall survival was obtained in the groups with FV and TLG above and below the threshold. On multivariate analysis of all the conventional prognostic factors and TLG more than 3340 and FV more than 416 cm 3, only age greater than 60 years (P=0.013) and FV more than 416 cm (P=0.012) were found to be independently associated with disease progression. CONCLUSION: Our results indicate that FV and TLG in staging PET/CT could be useful indices in predicting outcomes in patients with high-grade NHL treated with standard first-line chemotherapy regimens.
机译:目的:本研究旨在评估定量参数在分期PET在预测高级别非霍奇金淋巴瘤(NHL)患者预后中的作用。方法:本研究共纳入51例经组织病理学证实的高级NHL患者,这些患者接受了常规化学疗法的治疗。根据实体瘤的PET反应标准(PERCIST)标准定义总病变糖酵解(TLG)和功能量(FV)。对所有患者进行至少1年的随访或直到发生事件为止,以较早发生者为准。结果:在所研究的四个半定量参数中,SUV max和SUV均值与无进展生存期或总体生存期之间无统计学意义的相关性,而TLG和FV则显示了弱但有统计学意义的负相关性。使用接收器工作特性曲线分析,得出FV和TLG的最佳截止值,以预测进展和死亡。使用FV和TLG的临界值分别为416 cm 3和3340 g,在FV和TLG高于和低于阈值的组中,无进展生存期和总生存期在统计学上有显着差异。在对所有常规预后因素和TLG大于3340和FV大于416 cm 3进行多变量分析时,仅年龄大于60岁(P = 0.013)和FV大于416 cm(P = 0.012)是独立相关的随着疾病的发展。结论:我们的结果表明FV和TLG在PET / CT分期中可能是预测标准一线化疗方案治疗的高级NHL患者预后的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号